Item Details

Print View

Developments in the Prescription Drug Market: Oversight : Hearing Before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, Second Session, February 4, 2016

United States. Congress. House. Committee on Oversight and Government Reform
Format
EBook; Book; Government Document; Online
Published
Washington : U.S. Government Publishing Office, 2017.
Language
English
SuDoc Number
Y 4.G 74/7:114-132
Description
1 online resource (iii, 213 pages) : illustrations
Notes
  • Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
  • "Serial no. 114-132."
  • Includes bibliographical references.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Access in Virgo Classic
  • Staff View

    LEADER 02186nam a2200469 i 4500
    001 u7228609
    003 SIRSI
    005 20170727145935.0
    006 m o d f
    007 cr bn||||a||||
    008 170710s2017 dcua ob f000 0 eng c
    035
      
      
    a| (OCoLC)993261102
    042
      
      
    a| pcc
    043
      
      
    a| n-us---
    040
      
      
    a| GPO b| eng e| rda e| pn c| GPO d| GPO d| MvI
    049
      
      
    a| VA@@
    050
    1
    4
    a| KF27 b| .O94 2016u
    074
      
      
    a| 1016-C (online)
    086
    0
      
    a| Y 4.G 74/7:114-132
    088
      
      
    a| Serial no. 114-132 (United States. Congress. House. Committee on Oversight and Government Reform)
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Oversight and Government Reform, e| author.
    245
    1
    0
    a| Developments in the prescription drug market : b| oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
    264
      
    1
    a| Washington : b| U.S. Government Publishing Office, c| 2017.
    300
      
      
    a| 1 online resource (iii, 213 pages) : b| illustrations
    336
      
      
    a| text b| txt 2| rdacontent
    337
      
      
    a| computer b| c 2| rdamedia
    338
      
      
    a| online resource b| cr 2| rdacarrier
    500
      
      
    a| Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
    504
      
      
    a| Includes bibliographical references.
    500
      
      
    a| "Serial no. 114-132."
    650
      
    0
    a| Prescription pricing z| United States.
    650
      
    0
    a| Pharmaceutical industry x| Corrupt practices z| United States.
    650
      
    0
    a| Generic drugs x| Government policy z| United States.
    650
      
    0
    a| Drug approval z| United States.
    655
      
    7
    a| Legislative hearings. 2| lcgft
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Oversight and Government Reform. t| Developments in the prescription drug market w| (OCoLC)994629512
    856
    4
    0
    u| http://purl.fdlp.gov/GPO/gpo82526
    596
      
      
    a| 1
    999
      
      
    a| Y 4.G 74/7:114-132 w| SUDOC i| 7228609-1001 l| INTERNET m| UVA-LIB t| INTERNET
▾See more
▴See less

Availability

Google Preview

Google Books Preview

Read Online